Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

SmithKline Beecham stresses dual PDE IV and TNF production inhibitors

Sep. 6, 1996

Bock Pharmacal introduces antihistamine-free cough syrup

Sep. 6, 1996

Clearance for Schering-Plough's extended-release Claritin-D

Sep. 6, 1996

SKB claims NK3 antagonists for pulmonary disorders

Aug. 30, 1996

SKB reports on PDE IV inhibitor research

Aug. 30, 1996

Scirex to manage IND filing for Apanol

Aug. 30, 1996

Usherdex-4 and other dextrans covered under U.S. patent

Aug. 23, 1996

Forest's Infasurf earns approvable status

Aug. 23, 1996

FR-173657: Fujisawa's bradykinin B2 antagonist

Aug. 23, 1996

PAF antagonist Y-24180 enters phase III

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026